ARTV Artiva Biotherapeutics, Inc. - Common Stock
$11,78
Prix · Aoû 18, 2026
Données fondamentales au Aoû 6, 2026
Fourchette 52 semaines
$2–$15
78% of range
Note des analystes
BUY
12 analysts
Objectif de cours
$36
+204% upside
P/E (TTM)
-1.3
ROE
—
Marge nette
—
ARTV Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$11.78
Capitalisation Boursière
—
P/E (TTM)
-1.3
BPA (TTM)
$-3.43
Revenus (TTM)
$0
Rendement div.
—
ROE
—
Dette/Capitaux propres
—
Fourchette 52 semaines
$2 – $15
ARTV Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$0
2023-12-31
→
2025-12-31
BPA
$-3.43
2023-12-31
→
2025-12-31
Flux de trésorerie libre
—
2024-12-31
→
2024-12-31
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
ARTV
Médiane des pairs
P/E (TTM)
-1.3
19.6
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
ARTV
Médiane des pairs
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
ARTV
Médiane des pairs
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
ARTV
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
-99.2%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
ARTV
Médiane des pairs
ARTV Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
12 analystes
- Achat fort 4 33,3%
- Achat 7 58,3%
- Conserver 1 8,3%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
5 analystes · 2026-08-18
Médiane
$40.00
Moyenne
$35.80
← En dessous de tous les objectifs
$11.78
Bas
$23.00
Haut
$41.00
Objectif médian
$40.00
+239,6%
Objectif moyen
$35.80
+203,9%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-0.01%
Prochain rapport
Aoû 27, 2026
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-0.63 | $-0.64 | 0.01% |
| 31 mars 2026 | $-0.95 | $-0.89 | -0.06% |
| 31 décembre 2025 | $-0.85 | $-0.84 | -0.01% |
| 30 septembre 2025 | $-0.88 | $-0.89 | 0.01% |
| 30 juin 2025 | $-0.87 | $-0.82 | -0.05% |
| 31 mars 2025 | $-0.83 | $-0.72 | -0.11% |
| 31 décembre 2024 | $-0.66 | $-0.77 | 0.11% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| ARTV | — | -1.3 | -99.2% | — | — | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | — |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | — |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | — |
| EIKN | — | — | — | — | — | — |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | — |
| PRLD | — | -2.2 | 73.4% | -819.6% | -137.7% | — |
| KYTX | $568M | -2.6 | — | — | -77.4% | — |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 14
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $251.0K | $33M | |
| R&D Expense | $70M | $50M | $50M | |
| SG&A Expense | $20M | $17M | $14M | |
| Operating Expenses | $90M | $68M | $64M | |
| Operating Income | $-90M | $-67M | $-31M | |
| Other Non-op | $-14.0K | $157.0K | $195.0K | |
| Pretax Income | · | $-65M | $-29M | |
| Income Tax | $0 | $0 | $72.0K | |
| Net Income | $-84M | $-65M | $-29M | |
| EPS (Basic) | $-3.43 | $-5.81 | $-35.78 | |
| EPS (Diluted) | $-3.43 | $-5.81 | $-35.78 | |
| Shares (Basic) | 24,444,057 | 11,258,851 | 802,747 | |
| Shares (Diluted) | 24,444,057 | 11,258,851 | 802,747 | |
| EBITDA | · | $-65M | · |
Bilan 22
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $27M | $40M | $54M | |
| Short-term Investments | $81M | $145M | $23M | |
| Receivables | · | $0 | $1M | |
| Prepaid Expense | $5M | $3M | $1M | |
| Current Assets | $113M | $189M | $80M | |
| PP&E (Net) | $7M | $6M | $8M | |
| PP&E (Gross) | $15M | $12M | $12M | |
| Accum. Depreciation | $8M | $6M | $4M | |
| Other Non-current Assets | $458.0K | $267.0K | $392.0K | |
| Total Assets | $131M | $210M | $105M | |
| Accounts Payable | $355.0K | $1M | $614.0K | |
| Accrued Liabilities | $10M | $7M | $8M | |
| Current Liabilities | $13M | $12M | $12M | |
| Capital Leases | $8M | $11M | $13M | |
| Other Non-current Liabilities | · | $73.0K | $73.0K | |
| Total Liabilities | $21M | $23M | $51M | |
| Common Stock | $3.0K | $3.0K | · | |
| Retained Earnings | $-331M | $-247M | $-181M | |
| AOCI | $103.0K | $-129.0K | $308.0K | |
| Stockholders' Equity | $110M | $187M | $-162M | |
| Liabilities + Equity | $131M | $210M | $105M | |
| Shares Outstanding | 24,595,550 | 24,291,607 | 809,758 |
Flux de trésorerie 11
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $3M | $2M | $2M | |
| Stock-based Comp | $7M | $7M | $7M | |
| Other Non-cash | · | $930.0K | · | |
| Operating Cash Flow | $-77M | $-55M | $-47M | |
| CapEx | $3M | $642.0K | $3M | |
| Investing Cash Flow | $63M | $-120M | $-26M | |
| Stock Issued | $0 | $167M | · | |
| Net Stock Activity | · | $167M | · | |
| Financing Cash Flow | $9.0K | $162M | $24M | |
| Net Change in Cash | $-13M | $-13M | $-49M | |
| Free Cash Flow | · | $-56M | · |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | · | -26805.6% | · | |
| Net Margin | · | -26045.0% | · | |
| Pretax Margin | · | -26045.0% | · | |
| EBITDA Margin | · | -25837.0% | · | |
| ROA | · | -41.5% | · | |
| ROE | · | -33.7% | · | |
| ROIC | · | -36.0% | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | · | 15.4 | · | |
| Quick Ratio | · | 15.1 | · |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | |
| Receivables Turnover | · | 0.5 | · |
Taux de croissance 1
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | · | -99.2% | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $251.0K | · | |
| Net Income TTM | $-84M | $-65M | · | |
| Market Cap | · | $245M | · | |
| P/E | -1.3 | -1.7 | · | |
| P/S | · | 975.5 | · | |
| P/B | · | 1.3 | · | |
| P / Tangible Book | 0.9 | 1.3 | · | |
| P / Cash Flow | · | -4.4 | · | |
| P / FCF | · | -4.4 | · | |
| Earnings Yield | -80.0% | -57.6% | · |
Compte de résultat 12
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $251.0K | $2M | |
| R&D Expense | $22M | $19M | $17M | $18M | $18M | $17M | $13M | $14M | $12M | $11M | $11M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $3M | |
| Operating Expenses | $27M | $24M | $22M | $23M | $23M | $22M | $18M | $18M | $16M | $15M | $14M | |
| Operating Income | $-27M | $-24M | $-22M | $-23M | $-23M | $-22M | $-18M | $-18M | $-16M | $-14M | $-12M | |
| Other Non-op | $-1.0K | $2.0K | $-2.0K | $-3.0K | $-5.0K | $-4.0K | $-7.0K | $-6.0K | $23.0K | $147.0K | $168.0K | |
| Net Income | $-25M | $-24M | $-21M | $-22M | $-21M | $-20M | $-16M | $-17M | $-18M | $-14M | $-12M | |
| EPS (Basic) | $-0.63 | $-0.95 | $-0.85 | $-0.88 | $-0.87 | $-0.83 | $34.35 | $-0.92 | $-22.00 | $-17.24 | $-14.89 | |
| EPS (Diluted) | $-0.63 | $-0.95 | $-0.85 | $-0.88 | $-0.87 | $-0.83 | $34.35 | $-0.92 | $-22.00 | $-17.24 | $-14.89 | |
| Shares (Basic) | 39,413,236 | 24,678,420 | -48,758,466 | 24,481,722 | 24,378,823 | 24,341,978 | -9,258,946 | 18,896,829 | 811,210 | 809,758 | 2,206 | |
| Shares (Diluted) | 39,413,236 | 24,678,420 | -48,758,466 | 24,481,722 | 24,378,823 | 24,341,978 | -9,258,946 | 18,896,829 | 811,210 | 809,758 | 2,206 | |
| EBITDA | $-27M | $-24M | · | $-23M | $-23M | $-22M | · | $-18M | $-16M | · | · |
Bilan 22
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $301M | $21M | $27M | $26M | $28M | $30M | $40M | $56M | $34M | · | $54M | |
| Short-term Investments | $48M | $66M | $81M | $97M | $114M | $136M | $145M | $91M | $12M | · | $23M | |
| Receivables | · | · | · | · | · | · | · | $569.0K | $569.0K | · | $1M | |
| Prepaid Expense | $3M | $2M | $5M | $6M | $7M | $4M | $3M | $3M | $2M | · | $1M | |
| Current Assets | $352M | $89M | $113M | $130M | $149M | $170M | $189M | $151M | $50M | · | $80M | |
| PP&E (Net) | $6M | $6M | $7M | $7M | $7M | $7M | $6M | $7M | $7M | · | $8M | |
| PP&E (Gross) | $15M | $15M | $15M | $15M | $14M | $14M | $12M | $12M | $12M | · | $12M | |
| Accum. Depreciation | $10M | $9M | $8M | $8M | $7M | $7M | $6M | $5M | $5M | · | $4M | |
| Other Non-current Assets | $809.0K | $458.0K | $458.0K | $418.0K | $38.0K | $13.0K | $267.0K | $298.0K | $330.0K | · | $392.0K | |
| Total Assets | $369M | $106M | $131M | $149M | $169M | $191M | $210M | $226M | $76M | · | $105M | |
| Accounts Payable | $1M | $2M | $355.0K | $848.0K | $1M | $2M | $1M | $1M | $823.0K | · | $614.0K | |
| Accrued Liabilities | $10M | $6M | $10M | $7M | $6M | $6M | $7M | $8M | $6M | · | $8M | |
| Current Liabilities | $15M | $11M | $13M | $11M | $11M | $12M | $12M | $13M | $11M | · | $12M | |
| Capital Leases | $7M | $7M | $8M | $9M | $10M | $10M | $11M | $11M | $12M | · | $13M | |
| Other Non-current Liabilities | · | · | · | · | · | · | $73.0K | $73.0K | $74.0K | · | $73.0K | |
| Total Liabilities | $21M | $18M | $21M | $20M | $20M | $22M | $23M | $25M | $51M | · | $51M | |
| Common Stock | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | · | · | · | |
| Retained Earnings | $-379M | $-354M | $-331M | $-310M | $-288M | $-267M | $-247M | $-231M | $-213M | · | $-181M | |
| AOCI | $-21.0K | $-18.0K | $103.0K | $87.0K | $2.0K | · | $-129.0K | $338.0K | $121.0K | · | $308.0K | |
| Stockholders' Equity | $348M | $88M | $110M | $129M | $149M | $169M | $187M | $201M | $-191M | · | $-162M | |
| Liabilities + Equity | $369M | $106M | $131M | $149M | $169M | $191M | $210M | $226M | $76M | · | $105M | |
| Shares Outstanding | 48,792,279 | 24,716,672 | 24,291,607 | 24,544,904 | 24,393,524 | 24,363,119 | 24,291,607 | 24,287,144 | 814,202 | · | 809,758 |
Flux de trésorerie 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $692.0K | $666.0K | $666.0K | $662.0K | $641.0K | $628.0K | $614.0K | $627.0K | $603.0K | $587.0K | $594.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Other Non-cash | · | $307.0K | · | · | · | $-2M | · | · | · | · | · | |
| Operating Cash Flow | $-20M | $-21M | $-15M | $-19M | $-23M | $-20M | $-15M | $-12M | $-14M | $-15M | $-11M | |
| CapEx | $415.0K | $242.0K | $421.0K | $600.0K | $1M | $511.0K | $64.0K | $96.0K | $464.0K | $18.0K | $636.0K | |
| Investing Cash Flow | $18M | $15M | $16M | $16M | $21M | $10M | $-966.0K | $-131M | $1M | $10M | $-3M | |
| Stock Issued | · | · | · | · | · | · | $0 | · | · | · | · | |
| Financing Cash Flow | $283M | $-112.0K | $-121.0K | $-37.0K | $-72.0K | $239.0K | $-30.0K | $164M | · | · | $962.0K | |
| Net Change in Cash | $280M | $-6M | $1M | $-3M | $-2M | $-10M | $-16M | $22M | $-14M | $-5M | $-12M | |
| Free Cash Flow | · | $-21M | · | · | · | $-20M | · | · | · | · | · |
Rentabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -9.3% | -15.8% | · | -11.5% | -17.3% | -21.2% | · | -15.5% | -47.0% | · | · | |
| ROE | -10.1% | -18.3% | · | -13.0% | 101.1% | -24.1% | · | -17.4% | 18.7% | · | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 24.2 | 8.2 | · | 11.6 | 13.8 | 13.9 | · | 11.3 | 4.6 | · | · | |
| Quick Ratio | 24.0 | 8.0 | · | 11.1 | 13.2 | 13.6 | · | 11.1 | 4.4 | · | · |
Valorisation (TTM) 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-91M | $-87M | · | $-81M | $-77M | $-70M | · | $-38M | $-32M | · | · | |
| Market Cap | $473M | $159M | · | $70M | $37M | $73M | · | $375M | · | · | · | |
| P/E | -2.9 | -1.8 | · | -0.8 | -0.1 | -0.1 | · | -0.4 | · | · | · | |
| P/B | 1.4 | 1.8 | · | 0.5 | 0.2 | 0.4 | · | 1.9 | · | · | · | |
| P / Tangible Book | 1.4 | 1.8 | · | 0.5 | 0.2 | 0.4 | · | 1.9 | · | · | · | |
| P / Cash Flow | · | -7.6 | · | · | · | -3.7 | · | · | · | · | · | |
| P / FCF | · | -7.5 | · | · | · | -3.6 | · | · | · | · | · | |
| Earnings Yield | -34.3% | -54.8% | · | -122.0% | -1630.5% | -1366.3% | · | -249.4% | · | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Revenu | $0 | $251.0K | $33M |
| Marge d'exploitation % | — | -26805.6% | — |
| Résultat net | $-84M | $-65M | $-29M |
| BPA dilué | $-3.43 | $-5.81 | $-35.78 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ratio de liquidité | — | 15.4 | — |
| Ratio de liquidité réduite | — | 15.1 | — |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flux de trésorerie libre | — | $-56M | — |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 75 déclarants · $384.3M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 42 (+32 vs T. préc.) | 7 (+2 vs T. préc.) | 20 (+19 vs T. préc.) | 4 (-8 vs T. préc.) | +23.2M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $174 169 727 | 17 955 642 | 45,32% | Actions |
| VIKING GLOBAL INVESTORS LP | $25 260 410 | 2 604 166 | 6,57% | Actions |
| Blackstone Inc. | $23 313 339 | 2 403 437 | 6,07% | Actions |
| 5AM Venture Management, LLC | $22 827 049 | 2 353 304 | 5,94% | Actions |
| Venrock Adviser, LLC | $19 822 881 | 2 043 596 | 5,16% | Actions |
| FRANKLIN RESOURCES INC | $19 373 063 | 1 997 223 | 5,04% | Actions |
| Caligan Partners LP | $16 840 277 | 1 736 111 | 4,38% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $9 523 606 | 981 815 | 2,48% | Actions |
| SAMSARA BIOCAPITAL, LLC | $9 262 152 | 954 861 | 2,41% | Actions |
| Blue Owl Capital Holdings LP | $8 483 057 | 874 542 | 2,21% | Actions |
| Propel Bio Management, LLC | $6 755 429 | 696 436 | 1,76% | Actions |
| CITADEL ADVISORS LLC | $5 910 947 | 609 376 | 1,54% | Actions |
| SILVERARC CAPITAL MANAGEMENT, LLC | $5 092 500 | 525 000 | 1,33% | Actions |
| BOOTHBAY FUND MANAGEMENT, LLC | $3 049 438 | 314 375 | 0,79% | Actions |
| Nantahala Capital Management, LLC | $2 910 000 | 300 000 | 0,76% | Actions |
| Revelation Capital Management, LLC | $2 903 317 | 299 311 | 0,76% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $2 834 361 | 292 032 | 0,74% | Actions |
| Alyeska Investment Group, L.P. | $2 654 066 | 273 615 | 0,69% | Actions |
| ACUTA CAPITAL PARTNERS, LLC | $2 526 035 | 260 416 | 0,66% | Actions |
| KVP Capital Advisors, LP | $1 940 000 | 200 000 | 0,50% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $1 882 848 | 194 108 | 0,49% | Actions |
| UBS Group AG | $1 757 019 | 181 136 | 0,46% | Actions |
| SEVEN GRAND MANAGERS, LLC | $1 697 500 | 175 000 | 0,44% | Actions |
| STATE STREET CORP | $1 607 911 | 165 764 | 0,42% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $1 464 700 | 151 000 | 0,38% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $1 439 412 | 148 393 | 0,37% | Actions |
| ADAR1 Capital Management, LLC | $1 150 653 | 118 624 | 0,30% | Actions |
| Simplify Asset Management Inc. | $983 144 | 101 355 | 0,26% | Actions |
| VANGUARD GROUP INC | $890 973 | 207 686 | 0,23% | Actions |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $824 500 | 85 000 | 0,21% | Actions |
| TWO SIGMA INVESTMENTS, LP | $762 178 | 78 575 | 0,20% | Actions |
| DAFNA Capital Management LLC | $650 880 | 67 101 | 0,17% | Actions |
| Quadrature Capital Ltd | $478 647 | 49 345 | 0,12% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $434 686 | 44 813 | 0,11% | Actions |
| XTX Topco Ltd | $412 337 | 42 509 | 0,11% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $301 796 | 31 113 | 0,08% | Actions |
| Velan Capital Investment Management LP | $242 500 | 25 000 | 0,06% | Actions |
| Atom Investors LP | $221 684 | 22 854 | 0,06% | Actions |
| BAILARD, INC. | $200 790 | 20 700 | 0,05% | Actions |
| Nuveen Asset Management, LLC | $187 599 | 18 611 | 0,05% | Actions |
| Spark Investment Management LLC | $160 050 | 16 500 | 0,04% | Actions |
| GOLDMAN SACHS GROUP INC | $153 066 | 15 780 | 0,04% | Actions |
| Squarepoint Ops LLC | $144 094 | 14 855 | 0,04% | Actions |
| ALLIANCEBERNSTEIN L.P. | $135 606 | 13 980 | 0,04% | Actions |
| Vanguard Global Advisers, LLC | $116 187 | 11 978 | 0,03% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $115 391 | 11 896 | 0,03% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $59 170 | 6 100 | 0,02% | Actions |
| Russell Investments Group, Ltd. | $53 263 | 5 491 | 0,01% | Actions |
| State of Wyoming | $44 504 | 4 588 | 0,01% | Actions |
| WELLS FARGO & COMPANY/MN | $38 606 | 3 980 | 0,01% | Actions |
| FMR LLC | $34 513 | 3 558 | 0,01% | Actions |
| RHUMBLINE ADVISERS | $29 474 | 3 039 | 0,01% | Actions |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $20 719 | 2 136 | 0,01% | Actions |
| Federation des caisses Desjardins du Quebec | $19 400 | 2 000 | 0,01% | Actions |
| JPMORGAN CHASE & CO | $18 422 | 1 923 | 0,00% | Actions |
| CITIGROUP INC | $18 188 | 1 875 | 0,00% | Actions |
| China Universal Asset Management Co., Ltd. | $15 520 | 1 600 | 0,00% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $11 136 | 1 148 | 0,00% | Actions |
| NORTHERN TRUST CORP | $6 955 | 717 | 0,00% | Actions |
| BlackRock, Inc. | $5 781 | 596 | 0,00% | Actions |
| Legal & General Group Plc | $5 490 | 566 | 0,00% | Actions |
| Steward Partners Investment Advisory, LLC | $4 850 | 500 | 0,00% | Actions |
| BARCLAYS PLC | $4 792 | 494 | 0,00% | Actions |
| Ameritas Investment Partners, Inc. | $4 084 | 421 | 0,00% | Actions |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | $3 880 | 400 | 0,00% | Actions |
| Tower Research Capital LLC (TRC) | $2 396 | 247 | 0,00% | Actions |
| US BANCORP \DE\ | $2 280 | 235 | 0,00% | Actions |
| ROYAL BANK OF CANADA | $2 000 | 224 | 0,00% | Actions |
| MERCER GLOBAL ADVISORS INC /ADV | $1 940 | 200 | 0,00% | Actions |
| Quarry LP | $912 | 94 | 0,00% | Actions |
| Sterling Capital Management LLC | $698 | 72 | 0,00% | Actions |
| MORGAN STANLEY | $398 | 41 | 0,00% | Actions |
| ACADIAN ASSET MANAGEMENT LLC | $221 | 22 940 | 0,00% | Actions |
| Caitong International Asset Management Co., Ltd | $126 | 13 | 0,00% | Actions |
| JONES FINANCIAL COMPANIES LLLP | $106 | 11 | 0,00% | Actions |
Initiés de la société 9 initiés · 8 dirigeants · 2 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Fred Aslan | Chief Executive Officer | 19 mai 2026 S | 1 535 082 | 0 | 3 | $-284 985 |
| Thad Allen Huston | Chief Financial Officer | 10 mars 2026 A | 220 000 | 0 | 0 | $0 |
| Neha Krishnamohan | Chief Financial Officer | 15 novembre 2025 F | 99 356 | 0 | 0 | $0 |
| Gines Diego Miralles | President & Head of R&D | 18 mai 2026 A | 77 500 | 0 | 0 | $0 |
| Jennifer Bush | COO, CLO, Compliance Officer | 19 mai 2026 S | 337 920 | 0 | 1 | $-79 198 |
| Subhashis Banerjee | Chief Medical Officer | 19 mai 2026 S | 144 963 | 0 | 1 | $-63 403 |
| Heather Raymon | SVP, Research and Development | 19 mai 2026 S | 148 228 | 0 | 1 | $-27 886 |
| Christopher Horan | Chief Tech Operations Officer | 19 mai 2026 S | 293 450 | 0 | 1 | $-63 088 |
| Elaine K. Sorg | Administrateur | 18 février 2026 A | — | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 3 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 dépôts | 23 juillet 2026 | 37,90% | Amendement | — | SEC |
| GC Corp, GC Cell Corporation, Yong-Jun Huh | 28 mai 2026 | 12,30% | Amendement | — | SEC |
| GC Corp., GC Cell Corporation, Yong-Jun Huh | 29 juillet 2024 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 11 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 15 784 SH | 8 août 2026 | Quotidien |
| IWN · iShares Trust | 0,00% | 35 800 SH | 8 août 2026 | Quotidien |
| IWM · iShares Trust | 0,00% | 137 793 SH | 8 août 2026 | Quotidien |
| DCOR · Dimensional ETF Trust | 0,00% | 3 029 NS | 30 avril 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 269 149 SH | 8 août 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 699 899 SH | 8 août 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 26 837 SH | 8 août 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 934 SH | 8 août 2026 | Quotidien |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1 342 SH | 8 août 2026 | Quotidien |
| IWO · iShares Trust | 0,00% | 176 SH | 8 août 2026 | Quotidien |
| DFAS · Dimensional ETF Trust | 0,00% | 678 NS | 30 avril 2026 | N-PORT |